Development of transferrin-bearing vesicles encapsulating aspirin for cancer therapy
Sakpakdeejaroen, Intouch and Somani, Sukrut and Mullin, Margaret and Dufès, Christine (2019) Development of transferrin-bearing vesicles encapsulating aspirin for cancer therapy. Journal of Liposome Research. ISSN 0898-2104 (In Press)
Preview |
Text.
Filename: Sakpakdeejaroen_etal_JLR_2019_Development_of_transferrin_bearing_vesicles_encapsulating_aspirin_for_cancer_therapy.pdf
Accepted Author Manuscript Download (578kB)| Preview |
Abstract
Originally developed for the treatment of inflammatory disorders, the non-steroidal antiinflammatory drug aspirin was shown to have a preventive effect against cancer in the past decades. Most importantly, recent studies suggested that it might also provide a therapeutic benefit in the treatment of cancer in vitro. However, this drug failed to specifically reach tumors at a therapeutic concentration following intravenous administration, thus resulting in lack of efficacy on tumors. In this work, we demonstrated that aspirin could be formulated in transferrin-bearing vesicles and that this tumor-targeted formulation could lead to an increase in the anti-proliferative efficacy of the drug in three cancer cell lines in vitro. The in vitro therapeutic efficacy of aspirin was significantly improved when formulated in transferrin-bearing vesicles, by about 2-fold compared to that of drug solution. These results are promising and support the optimization of this delivery system to further improve its potential as a therapeutic tool in combination with other anti-cancer therapies.
ORCID iDs
Sakpakdeejaroen, Intouch


-
-
Item type: Article ID code: 67656 Dates: DateEvent22 April 2019Published22 April 2019AcceptedKeywords: aspirin, transferrin, tumor targeting, drug delivery, cancer therapy, Therapeutics. Pharmacology, Neoplasms. Tumors. Oncology (including Cancer), Pharmacology (medical), Oncology Subjects: Medicine > Therapeutics. Pharmacology
Medicine > Internal medicine > Neoplasms. Tumors. Oncology (including Cancer)Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 30 Apr 2019 14:16 Last modified: 11 Mar 2023 04:11 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/67656